NOT KNOWN FACTS ABOUT ESTAZOLAM

mavorixafor will boost the level or outcome of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Keep an eye on for adverse results of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).Significant Anaphylactic and Anaphylactoid Reactions Exceptional conditions of a